Vaccine Information Center

Infectious Diseases Information Center

FDA Panel Votes in Favor of Pfizer-BioNTech COVID-19 Vaccine for 5 to 11 Year-Olds

By

Diana Ernst, RPh

Publish Date October 27, 2021

The panel reviewed safety and efficacy data from a phase 2/3 study that included 2268 participants who received a 2-dose regimen of 10mcg administered 21 days apart.

Infectious Diseases Information Center

ACIP Recommends Updates to Pneumococcal Vaccination Guidelines

By

Brian Park, PharmD

Publish Date October 25, 2021

The update applies to patients who have not previously received a pneumococcal conjugate vaccine or whose previous vaccination history is unknown.

Infectious Diseases Information Center

FDA Expected to Allow Mix ‘n’ Match COVID-19 Vaccines

Publish Date October 20, 2021

Agency will not recommend one vaccine over another but may say it is preferable to use same booster as the vaccine.

Infectious Diseases Information Center

Flucelvax Quadrivalent Approval Expanded to Include Younger Patients

By

Brian Park, PharmD

Publish Date October 20, 2021

The expanded approval was based on data from a phase 3 study that compared Flucelvax Quadrivalent to a US-licensed comparator quadrivalent influenza vaccine.

Vaccine Information Center

What Should Parents Know About COVID-19 Vaccines?

By

Steve Fiorillo

Publish Date October 18, 2021

With children back in school and COVID-19 cases persisting, parents may be concerned and seek information about the vaccine. What should they know about the COVID-19 vaccine for children?

Infectious Diseases Information Center

NASEM: Building Parents’ Confidence in COVID-19 Vaccines

By

Kristin Della Volpe

Publish Date October 15, 2021

NASEM offers recommendations for communicating with parents of young children about COVID-19 vaccines.

Infectious Diseases Information Center

AAP Updates Influenza Vaccination Guidance for Children

By

Diana Ernst, RPh

Publish Date September 24, 2021

Routine annual influenza vaccination is recommended for all patients 6 months of age and older who have no medical contraindications.

News

Pfizer-BioNTech COVID-19 Vaccine Booster Dose Authorized for High-Risk Individuals

By

Brian Park, PharmD

Publish Date September 24, 2021

A single booster dose may be administered to individuals 65 years and older and those at high risk of severe disease or exposure to SARS-CoV-2.

Infectious Diseases Information Center

Booster Dose of J&J COVID-19 Vaccine May Increase Immunity

Publish Date September 22, 2021

New research indicates two doses of the vaccine boosts immunity from 74% to 94%

Infectious Diseases Information Center

President Biden Pushes American Workers to Take COVID-19 Vaccine

By

Jeanelle Jacobs

Publish Date September 22, 2021

President Joe Biden uses the full authority of his presidency to push Federal and health care workers to get vaccinated against COVID-19.

Infectious Diseases Information Center

COVID-19 Vaccines Prevent Hospitalizations in High-Risk Populations

Publish Date September 20, 2021

Estimates of vaccine effectiveness high for adults 85 years and older, those with chronic medical conditions, and for Hispanic and Black adults.

Infectious Diseases Information Center

Israeli Study Shows Pfizer Booster Gives Seniors Big Rise in Immunity

Publish Date August 24, 2021

A third dose of the Pfizer COVID-19 vaccine gives 4 times greater protection against COVID-19 infection, according to Israeli study.

Infectious Diseases Information Center

FDA Grants First Full Approval to Pfizer-BioNTech COVID-19 Vaccine

By

Steve Duffy

Publish Date August 23, 2021

Comirnaty is indicated for individuals 16 years of age and older, however the vaccine remains available to those aged 12 years and older under the EUA.

News

Decision on J&J COVID-19 Vaccine Booster Doses Could Take Weeks

Publish Date August 23, 2021

Federal health officials are waiting on clinical trial results to determine whether a second shot of the J&J vaccine or a booster using another vaccine is best.

Practice Management Information Center

US Plans on COVID-19 Booster Shots as Soon as September

By

Diana Ernst, RPh

Publish Date August 18, 2021

Americans will be able to start getting a booster of the mRNA COVID-19 vaccine starting September 20, 2021.

Infectious Diseases Information Center

United States Sees Big Spike in COVID-19 Vaccinations

Publish Date August 12, 2021

Daily number rose from 226,209 on July 5 to about 441,198 on Aug. 5

Infectious Diseases Information Center

COVID-19 Vaccine Safe, Recommended for Pregnant Women, CDC Says

Publish Date August 12, 2021

Latest recommendation comes after new data showed no raised risk for miscarriage in mothers-to-be during first 20 weeks

Infectious Diseases Information Center

White House Outlines Effort to Vaccinate Young as Schools Start to Reopen

Publish Date August 9, 2021

Push will include enlisting pediatricians to make COVID-19 vaccination part of back-to-school sports physicals.

Infectious Diseases Information Center

Moderna COVID-19 Vaccine Maintains Efficacy 6 Months After Second Dose

By

Brian Park, PharmD

Publish Date August 9, 2021

The efficacy data was based on a final analysis of the phase 3 COVE study which evaluated the mRNA-1273 vaccine in more than 30,000 adults aged 18 years and older.

Infectious Diseases Information Center

Pediatric Immunization Schedule: Best Available Evidence for 2021

By

Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP

Publish Date August 9, 2021

Review of the 2021 Advisory Committee Immunization Practices updates to the pediatric immunization schedule during COVID-19.